Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Trading Statement

14 Jul 2016 07:00

RNS Number : 1245E
Charlemagne Capital Limited
14 July 2016
 

14 July 2016

 

 

Interim Management Statement for the Six Months Ended 30 June 2016

 

Charlemagne Capital Limited (the "Group") sets out below the key revenue items and assets under management ("AuM") for the first six months of its current financial year. It is expected that the interim financial results will be announced in September 2016.

 

Key highlights and Group AuM

 

§ As at 30 June 2016, Group AuM were US$2.1 billion

§ Net management fees of US$9.0 million for the six months ended 30 June 2016

· The Group remains well-capitalised with a strong and liquid balance sheet

 

The table below sets out the Group's AuM as at 30 June 2016 and the movements experienced in each product range in the period since 1 January 2016.

 

01-Jan-16

Net Subscriptions

Net Performance

30-Jun-16

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

508

(45)

(8.9)

30

6.2

493

(3.0)

OCCO

493

23

4.7

25

5.0

541

9.7

Institutional

805

65

8.1

85

10.1

955

18.6

Specialist

91

11

12.1

(6)

(6.2)

96

5.5

Total

1,897

54

2.8

134

7.0

2,085

9.9

 

Notes:

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2016

 

Net management fees receivable were US$9.0 million compared with US$10.0 million for the previous six months and US$10.7 million for the comparable period of 2015, reflecting the fall in average AuM since that period and a small reduction in net revenue margin. OCCO management fees, which are subject to a minority interest, accounted for 46% of total net management fee income during the period.

 

Crystallised performance fees were US$0.3 million compared with US$0.7 million for the comparative period in 2015. Accruing performance fees1 for 2016 which have not crystallised were US$8.5 million, US$6.6 million of which relates to OCCO and are subject to a minority interest, compared with US$0.9 million as at the same date in 2015. Other income inclusive of gains/losses on investments held and foreign exchange was overall negative US$0.2 million for the period compared with positive income of US$0.4 million for the same period last year.

 

 

_________________________________________________________________________

1Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

Summary

 

Emerging markets ended the first half up having suffered a sharp decrease in values in the first two months and then recovered at the end of the first quarter. The MSCI Emerging markets index was up by 6.4% in US$ over the full half year after being down 6.6% at the end of February.

 

Overall flows for the Group were positive which is pleasing against a backdrop of continued industry outflows; however average AuM dipped in the first quarter and was down over the full period to US$1.9 billion compared to US$2.2 billion in the corresponding period last year and US$2.1 billion for 2015 as a whole. This current average level of AuM remains below the level required to ensure sustainable profits on a recurring management fee basis.

 

Outlook

 

The first half of 2016 saw emerging markets (EM) equities outperform developed markets, reversing a five-year trend. While the impact of the Brexit vote on developed markets was a sting in the tail at the end of the period, EM had led the way even before the 23rd June. There are several reasons for this. EM has been increasingly an unloved, and therefore under owned, asset class, trading at a historically low price to book ratio. The shrinking EM growth premium looks set to widen again, as countries like Brazil and Russia start to recover from deep slumps whilst at the same time growth in the likes of Japan and the UK are slowing. There are signs that market analysts are at last being more realistic (cautious) about estimating corporate earnings, which allows at least some chance that they might subsequently be exceeded.

 

The Group's investment performance remains strong. It was affected in the spring by the beta rally in commodity shares, which we generally don't own due to business models, ownership structures and earnings volatility. This didn't help our growth style. Despite this, five of the seven Magna strategies were in the top half of their respective FactSet Morningstar peer groups over the six months and six out of seven over 12 months.

 

The economic impact of an eventual Brexit on EMs should be modest, except in the remote event that globalisation is comprehensively reversed or there are other geopolitical shocks to the global economy. However, the UK vote means that policy risk in the heart of Europe may remain elevated, for many years, at levels unthinkable just a few years ago. The rise in populism and antiglobalism is also likely to be a key factor in the forthcoming US election. These factors could destabilise developed economies at a time when the economics of the EM countries are beginning to recover.

 

 

Enquiries:

 

Charlemagne Capital

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Finance Director

Tel. 01624 640200

N+1 Singer

Tel. 020 7496 3000

Nic Hellyer

Gillian Martin

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

Ged Brumby

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDRRBBBGLX
Date   Source Headline
20th Jan 20219:05 amRNSSecond Price Monitoring Extn
20th Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 202110:00 amRNSIssue of Equity and Total Voting Rights
12th Jan 20218:22 amRNSTR-1: Notification of major holdings
11th Jan 20214:35 pmRNSPrice Monitoring Extension
11th Jan 202111:31 amRNSIssue of Equity and Total Voting Rights
11th Jan 20219:00 amRNSTR-1: Notification of major holdings
11th Jan 20217:00 amRNSTR-1: Notification of major holdings
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
6th Jan 20215:32 pmRNSTR-1: Notification of major holdings
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn
20th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSTR-1: Notification of major holdings
19th Oct 20202:41 pmRNSWarrant Update
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
6th Oct 20203:08 pmRNSNew Website
14th Dec 20164:01 pmRNSScheme Effective
13th Dec 20164:15 pmRNSCourt Sanction of Scheme
13th Dec 20167:30 amRNSSuspension - Charlemagne Capital Limited
12th Dec 20168:05 amRNSDocument re: Charlemagne Capital
12th Dec 20168:01 amRNSSuspension of Dealings and Transfers
9th Dec 201610:55 amRNSDocument re: Charlemagne Capital
8th Dec 20161:22 pmRNSConfirmation of Regulatory Clearance
8th Dec 201611:36 amRNSDocument re: Charlemagne Capital
7th Dec 20164:25 pmRNSDocument re: Charlemagne Capital
7th Dec 20164:21 pmRNSDocument re: Charlemagne Capital
2nd Dec 20165:19 pmRNSResults of the Court Meeting
10th Nov 20167:00 amRNSScheme Circular
14th Oct 20163:05 pmRNSDocument re: Charlemagne Capital
12th Oct 20167:00 amRNSQ3 2016 AUM Update
3rd Oct 20163:30 pmRNSTR-1: Notification of Major Interest in Shares
30th Sep 20163:01 pmRNSOPD - Charlemagne Capital - Replacement
30th Sep 20162:50 pmRNSDoc re. Charlemagne Capital
30th Sep 20167:00 amRNSForm 8 (OPD) Charlemagne Capital plc
30th Sep 20167:00 amRNSRecommended Cash Offer for Charlemagne
30th Sep 20167:00 amRNSHalf Yearly Report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
14th Jul 20167:00 amRNSTrading Statement
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
17th Jun 20161:56 pmRNSResult of AGM
20th May 20164:38 pmRNSAnnual Report and Notice of AGM
28th Apr 20161:22 pmRNSTR-1: Notification of Major Interest in Shares
15th Apr 201610:08 amRNSTR-1: Notification of Major Interest in Shares
11th Apr 20167:00 amRNSQ1 2016 AUM Update
24th Mar 20169:16 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.